+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are evaluating the CARES Cancer Advocacy, Resources, Education and Support intervention to see if it improves the time to start treatment after diagnosis and the time to complete treatment for patients with solid tumors such as lung, head and neck, thyroid, cervical, breast, bladder, colon, and rectal cancers. This study focuses on patients living in rural areas and aims to compare the CARES intervention with usual care in a randomized setting. The study will enroll 320 participants who will be randomly assigned to either the CARES intervention or usual care groups. Those in the CARES intervention will receive up to 10 navigation sessions and 10 counseling sessions over approximately six months. These sessions are delivered by oncology nurse navigators and masters level counselors and may be conducted in person, virtually, or by phone. The usual care group will receive a standardized list of resources. All participants will complete surveys at the start of the study, 3 months, and 6 months to assess quality of care and patient-reported outcomes. Participants will be involved for six months during which they will complete surveys assessing their quality of care and personal health experiences. The study team will monitor the time to care from enrollment to study end to evaluate the impact of the intervention. Assessments will be done at baseline, 3 months, and 6 months to gather patient-reported outcomes and quality of care measures. This study is sponsored by the University of Colorado, Denver, and aims to improve care delivery for rural cancer patients.

Age: 18Years - 99YearsAll GendersPhase Not Applicable
14 locations
R

Actively Recruiting

Researchers are evaluating the safety and effectiveness of MaioRegen Prime compared to standard debridement surgery in patients with deep osteochondral lesions of the knee. This study involves patients with lesions of varying cause, size, shape, and location, and aims to assess outcomes through clinical, subjective, and objective measures. Participants are randomly assigned in a 21 ratio to receive either the MaioRegen Prime osteochondral scaffold implant or standard debridement surgery. All patients will have follow-up visits at 15 days, 6 weeks, 3, 6, 12, 18, and 24 months after surgery, with annual visits continuing until the last patient reaches 24 months. The study collects various clinical scores and MRI assessments to evaluate cartilage repair and knee function. During the study, participants will undergo evaluations including knee function questionnaires, pain scales, quality of life assessments, and MRI scans. Researchers will monitor clinical outcomes such as knee function scores, pain levels, cartilage repair quality, and any safety events or re-interventions. The total participation lasts at least 24 months, with continued annual follow-ups to track long-term outcomes.

Age: 18Years - 60YearsAll GendersPhase Not Applicable
10 locations
P

Actively Recruiting

Researchers are evaluating CARTISTEM, a new treatment made from stem cells derived from donated umbilical cord blood combined with a gel, to determine if it is safer and more effective than a standard surgical procedure called debridement for people with knee cartilage damage and osteoarthritis. This Phase 3 trial aims to show if CARTISTEM can reduce knee pain and improve function better than debridement two years after treatment. The study also investigates whether CARTISTEM may slow osteoarthritis progression using MRI scans. Participants will be divided into two groups one will receive CARTISTEM combined with debridement surgery, where the stem cell gel is placed into the damaged knee area after bone stimulation. The other group will undergo debridement surgery alone, which removes damaged cartilage and smooths the knee tissue. CARTISTEM involves mixing stem cells and a gel before placing it in the knee during surgery. Both groups will be monitored over two years. During the study, participants will have assessments of knee pain using the Visual Analog Scale and knee function using the WOMAC index from enrollment through 24 months. MRI scans will measure cartilage repair and osteoarthritis progression. Participants must follow rehabilitation requirements and limit other knee treatments during the trial. The study includes randomization and double-blinding to compare outcomes fairly while monitoring safety and effectiveness over time.

Age: 18Years - 75YearsAll GendersPhase 3
35 locations